Metropolitan Life Insurance CO Passage Bio, Inc. Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.66 - $6.49 $8,762 - $21,378	-3,294 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$6.24 - $10.2 $20,554 - $33,598	3,294 New	3,294 $20,000
Q4 2021 Mar 30, 2023	SELL	$6.24 - $10.2 $18,607 - $30,416	-2,982 Reduced 47.51%	3,294 $20,000
Q4 2021 Feb 15, 2022	SELL	$6.24 - $10.2 $18,607 - $30,416	-2,982 Reduced 47.51%	3,294 $21,000
Q3 2021 Jun 21, 2023	BUY	$9.73 - $15.52 $61,065 - $97,403	6,276 New	6,276 $62,000
Q3 2021 Mar 30, 2023	SELL	$9.73 - $15.52 $51,753 - $82,550	-5,319 Reduced 45.87%	6,276 $62,000
Q3 2021 Nov 15, 2021	SELL	$9.73 - $15.52 $51,753 - $82,550	-5,319 Reduced 45.87%	6,276 $63,000
Q2 2021 Jun 21, 2023	BUY	$12.44 - $19.45 $144,241 - $225,522	11,595 New	11,595 $153,000
Q2 2021 Mar 30, 2023	BUY	$12.44 - $19.45 $50,979 - $79,706	4,098 Added 54.66%	11,595 $153,000
Q2 2021 Aug 16, 2021	BUY	$12.44 - $19.45 $144,154 - $225,386	11,588 Added 165542.86%	11,595 $154,000
Q1 2021 Jun 26, 2023	BUY	$16.24 - $29.83 $121,751 - $223,635	7,497 New	7,497 $131 Million
Q1 2021 May 14, 2021	SELL	$16.24 - $29.83 $121,637 - $223,426	-7,490 Reduced 99.91%	7 $131,000
Q4 2020 Jun 22, 2023	BUY	$14.28 - $29.73 $107,057 - $222,885	7,497 New	7,497 $191,000
Q4 2020 Mar 30, 2023	BUY	$14.28 - $29.73 $39,598 - $82,441	2,773 Added 58.7%	7,497 $191,000
Q4 2020 Feb 16, 2021	BUY	$14.28 - $29.73 $39,598 - $82,441	2,773 Added 58.7%	7,497 $192,000
Q3 2020 Jun 26, 2023	BUY	$12.39 - $26.15 $58,530 - $123,532	4,724 New	4,724 $61,000
Q3 2020 Mar 30, 2023	BUY	$12.39 - $26.15 $247 - $523	20 Added 0.43%	4,724 $61,000
Q3 2020 Nov 13, 2020	BUY	$12.39 - $26.15 $247 - $523	20 Added 0.43%	4,724 $62,000
Q2 2020 Jun 26, 2023	BUY	$14.59 - $36.07 $68,631 - $169,673	4,704 New	4,704 $128,000
Q2 2020 Mar 30, 2023	BUY	$14.59 - $36.07 $68,631 - $169,673	4,704 New	4,704 $128,000
Q2 2020 Aug 14, 2020	BUY	$14.59 - $36.07 $68,631 - $169,673	4,704 New	4,704 $129,000

Others Institutions Holding PASG

# of Institutions

Shares Held

32.7M

Call Options Held

8.3K

Put Options Held

400

Orbimed Advisors LLC San Diego, CA

10.1M
Shares

$7.09 Million
0.19% of portfolio
Vestal Point Capital, LP New York, NY

6.05M
Shares

$4.24 Million
0.36% of portfolio
Versant Venture Management, LLC San Francisco, CA

4.03M
Shares

$2.82 Million
7.06% of portfolio
New Leaf Venture Partners, L.L.C. New York, NY

2.5M
Shares

$1.75 Million
2.4% of portfolio
Vanguard Group Inc Valley Forge, PA

2.07M
Shares

$1.45 Million
0.0% of portfolio

View Full List

About Passage BIO, Inc.

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $38.1M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

More about PASG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account